Aclarion added to PRISM Emerging Medical Devices Index

Aclarion, Inc. has been added to the PRISM Emerging Medical Devices Index, recognizing its innovative AI-driven diagnostic technology for chronic low back pain. The U.S. medical devices market is projected to reach nearly $315 billion by 2032. Aclarion's NOCISCAN technology offers a noninvasive diagnostic tool, addressing a $40 billion annual market for lumbar spine diagnostics and treatment, impacting 266 million patients globally.